EyePoint Pharmaceuticals, Inc.

Q1 2025 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filings
162
Total reported value, excl. options
$402 M
Manager Report Date Value ($000) Shares Option Type